Lifeward Ltd. (LFWD) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Lifeward Ltd. (LFWD:NASDAQ), powered by AI.

Current Price
$6.78
P/E Ratio
-0.4
Market Cap
8M
Sector
Healthcare
What is the Lifeward Ltd. stock price forecast?

Lifeward Ltd. is currently trading at $6.78. View real-time AI analysis on Alpha Lenz.

What is Lifeward Ltd. insider trading activity?

View the latest insider trading data for Lifeward Ltd. on Alpha Lenz.

What is Lifeward Ltd.'s P/E ratio?

Lifeward Ltd.'s P/E ratio is -0.4.

Lifeward Ltd.

NASDAQ · LFWD
$6.78-0.02(-0.29%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Lifeward Ltd.'s future dividend policy...
Alpha Chat Insight

Lifeward Ltd. trades at a P/E of -0.4 (undervalued) with modest ROE of -146.1%. 3Y revenue CAGR of 58.7% highlights clear growth momentum.

Ask for details

Company Overview

Lifeward Ltd. operates as a comprehensive healthcare solutions provider, primarily focusing on the development, production, and distribution of innovative medical devices and health management systems. The company's primary function is to enhance the quality of patient care through advanced technological solutions, making healthcare more accessible and efficient. Lifeward Ltd. serves a wide array of sectors, including hospitals, clinics, and home healthcare settings, offering a diverse portfolio of products ranging from diagnostic equipment to telehealth platforms. Notably, Lifeward Ltd. significantly impacts the medical technology and healthcare delivery industries, contributing to advancements in patient monitoring and management. The company's expertise in integrating cutting-edge technology with healthcare practices highlights its pivotal role in the rapidly evolving healthcare market. By continually advancing its product offerings and maintaining rigorous standards of quality and innovation, Lifeward Ltd. provides essential tools to healthcare providers, aiding in effective treatment and improved patient outcomes.

CEOMr. William Mark Grant
SectorHealthcare
IndustryMedical Devices
Employees80

Company Statistics

FY 2025

Profile

$7.87MMarket Cap
$22.03MRevenue
0.00Shares Out
80Employees

Margins

38.25%Gross
-63.16%EBITDA
-76.66%Operating
-90.63%Pre-Tax
-90.38%Net

Valuation

-0.40P/E
0.94P/B
0.36EV/Sales
-0.72EV/EBITDA
-0.47P/FCF

Growth (CAGR)

58.72%Rev 3Yr
38.06%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-74.60%ROA
-146.12%ROE
-63.28%ROIC

Financial Health

$2.17MCash & Cash Equivalents
$12.32MNet Debt
172.36%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Lifeward Ltd. (ticker: LFWD) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 80 employees. Market cap is $8M.

The current price is $6.78 with a P/E ratio of -0.4x and P/B of 0.94x.

ROE is -146.12% and operating margin is -76.66%. Annual revenue is $22M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Lifeward Ltd. (LFWD) Stock Forecast 2026 $6.78 — Price, Financials & Analyst Targets | Alpha Lenz